The effect of grape seed extracts on serum paraoxonase activities in streptozotocin-induced diabetic rats

Journal of Medicinal Food

Volumn 13, Issue 3, 2010, Pages 725-728

  Kiyici, Aysel ^a   Okudan, Nilsel ^a   Gökbel, Hakki ^a   Belviranli, Muaz ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

diabetes; grape seed extract; paraoxonase

Indexed keywords

ARYLDIALKYLPHOSPHATASE; CATECHIN; FLAVONOID; GRAPE SEED EXTRACT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROCYANIDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CACAO; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; RED WINE; STREPTOZOCIN DIABETES;

ANIMALS; ARYLDIALKYLPHOSPHATASE; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; GRAPE SEED EXTRACT; HUMANS; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

RATTUS; THEOBROMA CACAO; VITACEAE; VITIS VINIFERA;

EID: 77953773615     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2009.0232     Document Type: Article

References (37)

1. Wattanakit K, Folsom AR, Selvin E, Weatherley BD, Pankow JS, Brancati FL, Hirsch AT: Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 2005;180: 389-397.
2. Ceriello A, Motz E: Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004;24:816-823.
3. Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C: Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003;34:1563-1574.
4. Pinent M, Blay M, Blade MC, Salvado MJ, Arola L, Ardevol A: Grape seed-derived procyanidins have an antihyperglycemic effect in streptozotocin-induced diabetic rats and insulinomimetic activity in insulin-sensitive cell lines. Endocrinology 2004;145: 4985-4990.
5. Williamson G, Manach C: Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005;81(1 Suppl):243S-255S.
6. Bagchi D, Bagchi M, Stohs SJ, Das DK, Ray SD, Kuszynski CA, Joshi SS, PreussHG: Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology 2000;148:187-197.
7. Bagchi D, Garg A, Krohn RL, Bagchi M, Tran MX, Stohs SJ: Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol 1997;93:179-189.
8. Sato M, Maulik G, Ray PS, Bagchi D, Das DK: Cardioprotective effects of grape seed proanthocyanidin against ischemic reperfusion injury. J Mol Cell Cardiol 1999;31:1289-1297.
9. Juretic D, Tadijanovic M, Rekic B, Simean-Rudolf V, Reiner E, Baricic M: Serum paraoxonase activities in hemodialyzed uremic patients: cohort study. Clin Sci 2001;42:146-150.
10. Li WF, Costa LG, Furlong CE: Serum paraoxonase status: a major factor in determining resistance to organophosphates. J Toxicol Environ Health 1993;40:337-346.
11. Primo-Parma SL, Sorenson RC, Teiber J, La Du BN: The human serum paraoxonase=arylesterase gene (PON1) is one member of multigene family. Genomics 1996;33:498-509.
12. Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA: Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 1996;7:69-76.
13. Durrington PN, Mackness B, Mackness MI: Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:473-480.
14. Eckerson HW, Wyte MC, La Du BN: The human serum paraoxonase/ arylesterase polymorphism. Am J Hum Genet 1983;35: 1126-1138.
15. Mackness MI, Arrol S, Abbott C, Durrington PN: Protection of low-density lipoprotein against oxidative modification by highdensity lipoprotein associated paraoxonase. Atherosclerosis 1993; 104:129-135.
16. Ayub A, Mackness MI, Arrol S, Mackness B, Patel J, Durrington PN: Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol 1999;19:330-335.
17. Mohamed RH, Mohamed RH, Karam RA, Abd El-Aziz TA: The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease. Clin Biochem 2010;43: 553-558.
18. Kim NS, Kang K, Cha MH, Kang B-J, Moon J, Kang BK, Yu BC, Kim Y-S, Choi SM, Bang O-S: Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans. Biochem Biophys Res Commun 2007;364:157-162.
19. Can Demirdogen B, Turkanoglu A, Bek S, Sanisoglu Y, Demirkaya S, Vural O, Arnc E, Adal O: Paraoxonase=arylesterase ratio, PON1 192Q=R polymorphism and PON1 status are associated with increased risk of ischemic stroke. Clin Biochem 2008;41:1-9.
20. Gur M, Aslan M, Yildiz A, Yilmaz R, Selek S, Erel O, Ozdogru I: Paraoxonase and arylesterase activities in coronary artery disease. Eur J Clin Invest 2006;36:779-787.
21. Tartan Z, Orhan G, Kaŝkçioglu H, Uyarel H, Unal S, Ozer N, Ozay B, Ciloglu, F, Cam N: The role of paraoxonase (PON) enzyme in the extent and severity of the coronary artery disease in type-2 diabetic patients. Heart Vessels 2007;22:158-164.
22. Inoue M, Suehiro T, Nakamura T, Ikeda Y, Kumon Y, Hashimoto K: Serum arylesterase=diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes. Metabolism 2000;49:1400-1405.
23. Mackness B, Mackness MI, Arrol S, Turkie W, Julier K, Abuasha B, Miller JE, Boulton AJM, Durrington PN: Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis 1998;139:341-349.
24. Lakshman MR, Gottipati CS, Narasimhan SJ, Munoz J, Marmillot P, Nylen ES: Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus. Metabolism 2006;55:1201-1206.
25. Ikeda Y, Inoue M, Suehiro T, Arii K, Kumon Y, Hashimoto K: Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes. Acta Diabetol 2009;46:239-242.
26. Camuzcuoglu H, Toy H, Cakir H, Celik H, Erel O: Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus. J Womens Health (Lanchmt) 2009;18:1435-1439.
27. Bagchi D, Garg A, Krohn RL, Bagchi M, Tran MX, Stohs SJ: Oxygen free radical scavenging abilities of vitamin C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol 1997;95:179-189.
28. Yamakoshi J, Kataoka S, Koga T, Ariga T: Proanthocyanidin rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 1999;142:421-422.
29. Mazur A, Bayle D, Lab C, Rock E, Rayssiguier Y: Inhibitory effect of procyanidin-rich extracts on LDL oxidation in vitro. Atherosclerosis 1999;145:421-422.
30. Vinson J, Proch J, Bose P: MegaNatural gold grapeseed extract: in vitro antioxidant and in vivo human supplementation studies. J Med Food 2001;4:17-26.
31. Bagchi D, Sen CK, Ray SD, Bagchi M, Preuss HG, Vinson JA: Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat Res 2003;523-524:87-97.
32. Clifton PM: Effect of grape seed extract and quercetin on cardiovascular and endothelial parameters in high-risk subjects. J Biomed Biotechnol 2004;2004:272-278.
33. Peng N, Clark JT, Prasain J, Kim H, White CR, Wyss JM: Antihypertensive and cognitive effects of grape polyphenols in estrogen- depleted, female, spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2005;289:R771-R775.
34. Kar P, Laight D, Shaw KM, Cummings MH: Flavonoid-rich grapeseed extracts: a new approach in high cardiovascular risk patientŝ Int J Clin Pract 2006;60:1484-1492.
35. Fujii H, Yokozawa T, Kim YA, Tohda C, Gen-ichiro N: Protective effect of grape seed polyphenols against high glucose induced oxidative stress. Biosci Biotechnol Biochem 2006;70: 2104-2111.
36. Vigna GB, Costantini F, Aldini G, Carini M, Catapano A, Schena F, Tangerini A, Zanca R, Bombardelli E, Morazzoni P, Mezzetti A, Fellin R, Maffei Facino R: Effect of a standardized grape seed extract on low-density lipoprotein susceptibility to oxidation in heavy smokers. Metabolism 2003;52:1250-1257.
37. Preuss HG, Wallerstedt D, Talpur N, Tutuncuoglu SO, Echard B, Myers A, Bui M, Bagchi D: Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study. J Med 2000;31: 227-247.